| Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning A Aiuti, S Slavin, M Aker, F Ficara, S Deola, A Mortellaro, S Morecki, ... Science 296 (5577), 2410-2413, 2002 | 1350 | 2002 |
| Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients M Introna, G Lucchini, E Dander, S Galimberti, A Rovelli, A Balduzzi, ... Biology of blood and marrow transplantation 20 (3), 375-381, 2014 | 224 | 2014 |
| Safety of retroviral gene marking with a truncated NGF receptor C Bonini, M Grez, C Traversari, F Ciceri, S Marktel, G Ferrari, M Dinauer, ... Nature medicine 9 (4), 367-369, 2003 | 181 | 2003 |
| Helper B cells promote cytotoxic T cell survival and proliferation independently of antigen presentation through CD27/CD70 interactions S Deola, MC Panelli, D Maric, S Selleri, NI Dmitrieva, CY Voss, H Klein, ... The Journal of Immunology 180 (3), 1362-1372, 2008 | 76 | 2008 |
| Next generation sequencing: new tools in immunology and hematology A Mori, S Deola, L Xumerle, V Mijatovic, G Malerba, V Monsurrò Blood research 48 (4), 242, 2013 | 57 | 2013 |
| Induction of pro-inflammatory programs in enteroendocrine cells by the Toll-like receptor agonists flagellin and bacterial LPS S Selleri, M Palazzo, S Deola, E Wang, A Balsari, FM Marincola, C Rumio International immunology 20 (8), 961-970, 2008 | 54 | 2008 |
| Phase II study of sequential infusion of donor lymphocyte infusion and cytokine-induced killer cells for patients relapsed after allogeneic hematopoietic stem cell transplantation M Introna, F Lussana, A Algarotti, E Gotti, R Valgardsdottir, C Micò, ... Biology of Blood and Marrow Transplantation 23 (12), 2070-2078, 2017 | 46 | 2017 |
| Molecular signatures induced by interleukin-2 on peripheral blood mononuclear cells and T cell subsets P Jin, E Wang, M Provenzano, S Deola, S Selleri, J Ren, S Voiculescu, ... Journal of translational medicine 4 (1), 1-23, 2006 | 45 | 2006 |
| Genomic loss of patient-specific HLA in acute myeloid leukemia relapse after well-matched unrelated donor HSCT C Toffalori, I Cavattoni, S Deola, S Mastaglio, F Giglio, B Mazzi, ... Blood, The Journal of the American Society of Hematology 119 (20), 4813-4815, 2012 | 42 | 2012 |
| Polarized monocyte response to cytokine stimulation D Nagorsen, S Deola, K Smith, E Wang, V Monsurro, P Zanovello, ... Genome biology 6 (2), 1-16, 2005 | 30 | 2005 |
| Delayed polarization of mononuclear phagocyte transcriptional program by type I interferon isoforms DF Stroncek, C Basil, D Nagorsen, S Deola, E Aricó, K Smith, E Wang, ... Journal of Translational Medicine 3 (1), 1-21, 2005 | 21 | 2005 |
| Two hits in one: whole genome sequencing unveils LIG4 syndrome and urofacial syndrome in a case report of a child with complex phenotype A Fadda, F Butt, S Tomei, S Deola, B Lo, A Robay, A Al-Shakaki, ... BMC medical genetics 17 (1), 1-7, 2016 | 19 | 2016 |
| Granulocyte transfusions in children and adults with hematological malignancies: benefits and controversies C Cugno, S Deola, P Filippini, DF Stroncek, S Rutella Journal of Translational Medicine 13 (1), 1-17, 2015 | 19 | 2015 |
| IL-3 or IL-7 increases ex vivo gene transfer efficiency in ADA-SCID BM CD34+ cells while maintaining in vivo lymphoid potential F Ficara, DB Superchi, RJ Hernández, C Mocchetti, N Carballido-Perrig, ... Molecular Therapy 10 (6), 1096-1108, 2004 | 18 | 2004 |
| Optimisation of retroviral supernatant production conditions for the genetic modification of human CD34+ cells JS Dando, A Aiuti, S Deola, F Ficara, C Bordignon The journal of gene medicine 3 (3), 219-227, 2001 | 18 | 2001 |
| GM-CSF/IL-3/IL-5 receptor common β chain (CD131) expression as a biomarker of antigen-stimulated CD8+ T cells S Selleri, S Deola, Z Pos, P Jin, A Worschech, SL Slezak, C Rumio, ... Journal of Translational Medicine 6 (1), 1-10, 2008 | 17 | 2008 |
| Mobilized Blood CD34+ Cells Transduced and Selected with a Clinically Applicable Protocol Reconstitute Lymphopoiesis in SCID-Hu Mice S Deola, S Scaramuzza, RS Birolo, N Carballido-Perrig, F Ficara, ... Human gene therapy 15 (3), 305-311, 2004 | 16 | 2004 |
| Bendamustine salvage for the treatment of relapsed Hodgkin’s lymphoma after allogeneic bone marrow transplantation M Mian, M Farsad, N Pescosta, M Casini, IM Cavattoni, S Deola, ... Annals of hematology 92 (1), 121-123, 2013 | 11 | 2013 |
| Abnormal cervical cytology after allogeneic bone marrow transplantation G Negri, M Herz, S Deola, A Piccin, M Casini, B Babich, M Tauber, ... American Journal of Clinical Pathology 142 (2), 222-226, 2014 | 9 | 2014 |
| Molecular purging of multiple myeloma cells by ex-vivo culture and retroviral transduction of mobilized-blood CD34+ cells S Deola, S Scaramuzza, RS Birolo, M Cergnul, F Ficara, J Dando, ... Journal of Translational Medicine 5 (1), 1-10, 2007 | 7 | 2007 |
